Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Double-Blind, Placebo-Controlled Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Sponsor: University of Texas Southwestern Medical Center
This PHASE2/PHASE3 trial investigates Generalized Lipodystrophy and Hypoleptinemia and is currently completed. University of Texas Southwestern Medical Center leads this study, which shows 12 recorded versions since 2006 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2023 — Apr 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2_PHASE3
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2_PHASE3
-
May 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Apr 2019 — May 2019 [monthly]
Completed PHASE2_PHASE3
-
Nov 2018 — Apr 2019 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Completed PHASE2_PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2_PHASE3
First recorded
Apr 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .